Michael P. Winegar

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Enpath Medical, Inc. designs, develops, manufactures and markets single use medical device products. The company was founded in 1985 and is headquartered in Minneapolis, MN.

ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support.

Myocor, Inc. develops products for the treatment of mitral regurgitation and congestive heart failure. It has two products in clinical trials that are designed to improve the pumping efficiency of the heart and thus improve the quality of life of patients. The company was founded in 1996 by Cyril J. Schweich and Todd Mortier and is headquartered in Maple Grove, MN.

Kips Bay Medical, Inc. was a medical device company focused on developing, manufacturing and commercializing its proprietary external saphenous vein support technology for use in coronary artery bypass grafting surgery. Its product, eSVS MESH, was a nitinol mesh sleeve that was placed over the saphenous vein graft during CABG surgery and is designed to constrict the vein and prevent expansion of the vein graft and resulting injury due to increased pressure. The company was founded by Manuel A. Villafaña on May 1, 2007 and was headquartered in Minneapolis, MN.

Mardil, Inc. manufactures and markets cardiovascular medical devices. The firm’s flagship product vent ouch system offers a therapy that addresses the underlying root cause mechanism of functional mitral valve regurgitation through a minimally invasive procedure. The company was founded in 2002 by Srirama Rao, Jai Raman and Gopal Muppirala and is headquartered in Plymouth, MN.